PRIA Logo™
TennesseeHB 1984114th General Assembly (2025-2026)HouseWALLET

AN ACT to amend Tennessee Code Annotated, Title 53, Chapter 11, relative to the use of buprenorphine products.

Sponsored By: Timothy Hill (Republican)

Signed by Governor

Controlled Substances

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

Analyzed Economic Effects

1 provisions identified: 0 benefits, 0 costs, 1 mixed.

On-site buprenorphine for addiction treatment, tighter limits

Healthcare providers can give buprenorphine without naloxone to treat addiction, but only at the clinic where it is dispensed. They must act within their scope and have an order from a Tennessee-licensed physician or another authorized prescriber named in state law. Providers cannot give these mono products for you to take home. Prescribers and pharmacies may use buprenorphine without naloxone only if you are pregnant, are nursing, have a documented bad reaction to naloxone, or are getting an injectable mono product.

Sponsors & Cosponsors

Sponsor

  • Timothy Hill

    Republican • House

Cosponsors

  • John Crawford

    Republican • House

  • Rusty Grills

    Republican • House

  • Gary Hicks

    Republican • House

  • Dawn White

    Republican • Senate

Roll Call Votes

All Roll Calls

Yes: 136 • No: 4

House vote • 3/30/2026

FLOOR VOTE: CONSENT CALENDAR PASSAGE ON THIRD CONSIDERATION 3/30/2026

Yes: 82 • No: 1

Senate vote • 3/30/2026

FLOOR VOTE: Third Consideration 3/30/2026

Yes: 28 • No: 3

House vote • 3/26/2026

HOUSE CALENDAR & RULES COMMITTEE

Yes: 0 • No: 0

House vote • 3/17/2026

HOUSE HEALTH COMMITTEE

Yes: 20 • No: 0

House vote • 2/18/2026

HOUSE HEALTH SUBCOMMITTEE

Yes: 6 • No: 0

Actions Timeline

  1. Signed by Governor.

    4/16/2026

  2. Transmitted to Governor for his action.

    4/7/2026House

  3. Signed by H. Speaker

    4/6/2026House

  4. Signed by Senate Speaker

    4/6/2026Senate

  5. Enrolled; ready for sig. of H. Speaker.

    4/1/2026House

  6. Passed H., Ayes 82, Nays 1, PNV 10

    3/30/2026House

  7. Engrossed; ready for transmission to Sen.

    3/30/2026House

  8. Sponsor(s) Added.

    3/30/2026House

  9. Received from House, Passed on First Consideration

    3/30/2026Senate

  10. Senate substituted House Bill for companion Senate Bill.

    3/30/2026Senate

  11. Passed Senate, Ayes 28, Nays 3

    3/30/2026Senate

  12. H. Placed on Consent Calendar for 3/30/2026

    3/26/2026House

  13. Placed on cal. Calendar & Rules Committee for 3/26/2026

    3/25/2026House

  14. Rec. for pass; ref to Calendar & Rules Committee

    3/17/2026House

  15. Placed on cal. Health Committee for 3/17/2026

    3/11/2026House

  16. No Action Taken

    3/10/2026House

  17. Placed on cal. Health Committee for 3/10/2026

    3/4/2026House

  18. Action def. in Health Committee to 3/10/2026

    3/3/2026House

  19. Sponsor(s) Added.

    2/25/2026House

  20. Placed on cal. Health Committee for 3/3/2026

    2/25/2026House

  21. Rec. for pass by s/c ref. to Health Committee

    2/18/2026House

  22. Sponsor(s) Added.

    2/12/2026House

  23. Sponsor change.

    2/11/2026House

  24. Sponsor(s) withdrawn.

    2/11/2026House

  25. Placed on s/c cal Health Subcommittee for 2/18/2026

    2/11/2026House

Bill Text

Related Bills

Back to State Legislation